Human immunodeficiency virus (HIV) is one of the most important sexually transmitted pathogens and a major public health concern for sexually transmitted infections (STIs) globally (1) (2) (3) (4) (5) . An estimated 34 million (31.6-35.2 million) people worldwide were living with HIV infection and/or AIDS at the end of 2010 (6). Globally, approximately 2.7 million (2.4-2.9 million) people were newly infected in 2010 (6) as compared to approximately 2.6 million (2.3-2.8 million) new infections in 2009 and 3.1 million (2.9-3.4 million) in 1997; this indicates a declining trend of new HIV infections (7) . Moreover, a decreasing trend in individuals with HIV and/or AIDS as well as a decline in new HIV infections was observed in 33 countries (7) . However, an earlier report reveals a significant increase in the rate of sexually transmitted diseases (STDs) as well as HIV infections in STD populations (8, 9) ; further, more individuals among the urban population were affected by HIV than those among the rural population (1, 8) . Additionally, HIV seroprevalence varied with the marital status of the attendees (1, 8) . The HIV infection rate in 2009 varied significantly in different countries globally as follows: 5.0z, sub-Saharan Africa; 0.2z, North Africa and the Middle East; 0.3z, South and SouthEast Asia; 0.5z, North and South America; 0.8z, Eastern Europe and Central Asia; and 0.2z, Western and Central Europe (7). In India, HIV infections emerged in the mid 1980s, and there was a rapid increase in its incidence and prevalence (10) . Unprotected sex is the major route of HIV transmission, and it contributes to approximately 88.7z (87.4z heterosexual and 1.3z homosexual) of the estimated HIV infections in India (11) .
In 2009, the National AIDS Control Organization (NACO) estimated that 2.39 million (1.93-3.04 million) people were living with HIV infections and/or AIDS in India, with the estimated new infections and adult prevalence being 0.12 million and 0.31z, respectively (11, 12) . In India, among patients attending an STD clinic, seropositivity of HIV was estimated to be 1.4z -14z with a higher incidence observed among commercial sex workers (CSWs) than the non-CSWs in 1995 (13) . It has been reported that there is a high prevalence of HIV transmission among high-risk populations of CSWs, patients at STD clinics, intravenous drug users, and commercial blood donors in India (14); moreover, a high incidence of HIV infections was observed in STD clinic attendees (15, 16) . Earlier reports have estimated that HIV seropositivity among STD clinic attendees in Calcutta, West Bengal (17-19) during 1988-2000 was approximately 1.3z-2.3z; however, there are no reports on the current scenario.
The present study aims to understand the occurrence of HIV in both male and female patients of different age groups attending an STD clinic of West Bengal.
Blood samples from 250 attendees were collected within a time span of 12 weeks (October-December) every year from 2004 to 2008 (total, 1,250 samples) in a consecutive manner, and an unlinked anonymous testing strategy was followed. An aliquot of unused serum was taken and given only a code number such that there The screening assay for HIV was performed using ELISA (Microlisa HIV; J. Mitra & Co., New Delhi, India) followed by the rapid (HIV Tri-Dot; J. Mitra & Co.) test performed with ELISA positive sera; Western blot (NEW LAV BLOT 1; Bio-Rad Laboratories, Hercules, Calif., USA) was performed as a confirmatory assay. Ethical approval was obtained as per HIV Sentinel Surveillance of NACO, New Delhi.
Out of 1,250 samples collected, 20 (1.60z) were found to be positive by ELISA, which was a sensitive screening assay. These positive samples were further tested by a specific rapid test. HIV sero-status was finally confirmed by Western blot assay. Finally, 16 (1.28z) individuals were found to be seropositive (men: 10, 1.48z; women: 6, 1.04z) by both rapid and Western blot assay with a statistically insignificant difference between male and female individuals ( x 2 ＝ 1.0, df ＝ 1, P À 0.05) and the results are documented in Table 1 . All positive sera were found to be HIV-1 reactive; none were found to be HIV-2 reactive. Seroprevalence of HIV among STD patients showed a sharp decline from 2.4z (2004) (2007), which was statistically insignificant ( x 2 ＝ 4.2, df ＝ 2, P À 0.05); this was followed by a significant increase (x 2 ＝ 4.6, df ＝ 1, P º 0.05) in 2008 (4.65z). Table 2 shows the seroprevalence of HIV in STD clinic attendees of different age groups. The prevalence was highest (1.66z) in the 25-29 age group followed by the 20-24 (1.29z), 45-49 (1.11z), 30-34 (1.06z), 35-39 (1.06z), and 15-19 (0.95z) age groups. The lowest prevalence was observed in the 40-44 age group (0.87z). Moreover, this difference among the age groups was found to be statistically insignificant ( x 2 ＝ 0.36, df ＝ 6, P À 0.05). Analysis by the x 2 test was performed to study the trends.
The present study revealed a decreasing seroprevalence of HIV in 4 consecutive years (2004-2007) with a minor increase in 2008 and an overall seropositivity of 1.28z (range by 5 consecutive years, 2.4z-1.6z) in STD clinic attendees, which is lower than the observed seroprevalence of 2.3z in West Bengal (19) and 2.25z-3.2z in Calcutta (18) However, a significant increase in HIV prevalence among men in 2008 reveals an acute need for a continued expansion of HIV and syphilis screening programs along with the implementation of effective targeted intervention strategies that could play an important role in reducing the HIV infection in this high risk group.
